Regarding IFN-γ-producing CD3+CD4− cells, cells isolated from patients receiving biologic therapy showed a significantly higher decrease in IFN-γ production following GA in vitro treatment compared to those isolated by patients naïve to therapy for psoriasis vulgaris (Online Resource 5). The gene discussed is IFNG; the disease is psoriasis vulgaris.